Surrogate markers of immune function in human immunodeficiency virus-infected patients: What are they surrogates for?

被引：4

作者：

Hengel, RL

Kovacs, JA

机构：

[1] NIAID, Immunoregulat Lab, NIH, Bethesda, MD 20892 USA

[2] NIH, Warren Grant Magnuson Clin Ctr, Dept Crit Care Med, Bethesda, MD 20892 USA

[3] Georgetown Univ, Washington, DC USA

来源：

JOURNAL OF INFECTIOUS DISEASES | 2003年 / 188卷 / 12期

关键词：

D O I：

10.1086/379901

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：1791 / 1793

页数：3

共 11 条

[1] Positive effects of combined antiretroviral therapy on CD4(+) T cell homeostasis and function in advanced HIV disease [J].

Autran, B ;

Carcelain, G ;

Li, TS ;

Blanc, C ;

Mathez, D ;

Tubiana, R ;

Katlama, C ;

Debre, P ;

Leibowitch, J .

SCIENCE, 1997, 277 (5322) :112-116

[2] HIV infection induces changes in CD4(+) T-cell phenotype and depletions within the CD4(+) T-cell repertoire that are not immediately restored by antiviral or immune-based therapies [J].

Connors, M ;

Kovacs, JA ;

Krevat, S ;

GeaBanacloche, JC ;

Sneller, MC ;

Flanigan, M ;

Metcalf, JA ;

Walker, RE ;

Falloon, J ;

Baseler, M ;

Stevens, R ;

Feuerstein, I ;

Masur, H ;

Lane, HC .

NATURE MEDICINE, 1997, 3 (05) :533-540

[3] Discontinuation of Mycobacterium avium complex prophylaxis in patients with antiretroviral therapy-induced increases in CD4+ cell count -: A randomized, double-blind, placebo-controlled trial [J].

Currier, JS ;

Williams, PL ;

Koletar, SL ;

Cohn, SE ;

Murphy, RL ;

Heald, AE ;

Hafner, R ;

Bassily, EL ;

Lederman, HM ;

Knirsch, C ;

Benson, CA ;

Valdez, H ;

Aberg, JA ;

McCutchan, JA .

ANNALS OF INTERNAL MEDICINE, 2000, 133 (07) :493-503

[4]

Hengel RL, 1999, J IMMUNOL, V163, P3539

[5] CD4+ T-lymphocyte nadir and the effect of highly active Antiretroviral therapy on phenotypic and functional immune restoration in HIV-1 infection [J].

Lange, CG ;

Valdez, H ;

Medvik, K ;

Asaad, R ;

Lederman, MM .

CLINICAL IMMUNOLOGY, 2002, 102 (02) :154-161

[6] Incomplete immune reconstitution after initiation of highly active antiretroviral therapy in human immunodeficiency virus-infected patients with severe CD4+ cell depletion [J].

Lederman, HM ;

Williams, PL ;

Wu, JW ;

Evans, TG ;

Cohn, SE ;

McCutchan, JA ;

Koletar, SL ;

Hafner, R ;

Connick, E ;

Valentine, FT ;

McElrath, MJ ;

Roberts, NJ ;

Currier, JS .

JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (12) :1794-1803

[7] Plasma viral load and CD4(+) lymphocytes as prognostic markers of HIV-1 infection [J].

Mellors, JW ;

Munoz, A ;

Giorgi, JV ;

Margolick, JB ;

Tassoni, CJ ;

Gupta, P ;

Kingsley, LA ;

Todd, JA ;

Saah, AJ ;

Detels, R ;

Phair, JP ;

Rinaldo, CR .

ANNALS OF INTERNAL MEDICINE, 1997, 126 (12) :946-954

[8] Immune restoration does not invariably occur following long-term HIV-1 suppression during antiretroviral therapy [J].

Pakker, NG ;

Kroon, EDMB ;

Roos, MTL ;

Otto, SA ;

Hall, D ;

Wit, FWNM ;

Hamann, D ;

van der Ende, ME ;

Claessen, FAP ;

Kauffmann, RH ;

Koopmans, PP ;

Kroon, FP ;

ten Napel, CHH ;

Sprenger, HG ;

Weigel, HM ;

Montaner, JSG ;

Lange, JMA ;

Reiss, P ;

Schellekens, PTA ;

Miedema, F .

AIDS, 1999, 13 (02) :203-212

[9] THE RISK OF PNEUMOCYSTIS-CARINII PNEUMONIA AMONG MEN INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1 [J].

PHAIR, J ;

MUNOZ, A ;

DETELS, R ;

KASLOW, R ;

RINALDO, C ;

SAAH, A .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (03) :161-165

[10] Response to immunization with recall and neoantigens after prolonged administration of an HIV-1 protease inhibitor-containing regimen [J].

Valdez, H ;

Smith, KY ;

Landay, A ;

Connick, E ;

Kuritzkes, DR ;

Kessler, H ;

Fox, L ;

Spritzler, J ;

Roe, J ;

Lederman, MB ;

Lederman, HM ;

Evans, TG ;

Heath-Chiozzi, M ;

Lederman, MM .

AIDS, 2000, 14 (01) :11-21

← 1 2 →